Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 4Phase 1/2 4

Status

Completed 5

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 2Lymphoid 1Head & Neck 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Lymphoma, T-Cell, Peripheral 1Lung Neoplasms 1Glioma 1Glioblastoma 1

Interventions

Cyclophosphamide 517Bevacizumab 488Carboplatin 424pembrolizumab 388Paclitaxel 385Gemcitabine 372Cisplatin 366Docetaxel 323Rituximab 316Radiotherapy 296Nivolumab 247Doxorubicin 243Dexamethasone 240Fluorouracil 225Capecitabine 214Oxaliplatin 211Erlotinib Hydrochloride 206fludarabine phosphate 201Etoposide 188Cetuximab 186Lenalidomide 177Pemetrexed 176Bortezomib 174Trastuzumab 173Filgrastim 171fludarabine 166Prednisone 166Leucovorin 166Cytarabine 166Irinotecan 161

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Has results × Protons × Clear all
NCT02314364 2025-12-16

A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC

Massachusetts General Hospital

Phase 2 Completed
27 enrolled 9 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT03132532 2025-11-25

Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Mayo Clinic

Phase 2 Completed
20 enrolled 20 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03778294 2025-07-03

18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy

Mayo Clinic

Phase 2 Completed
43 enrolled 19 charts
CNS

Glioblastoma, Glioma

NCT00592501 2021-10-26

Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma

Massachusetts General Hospital

Phase 2 Completed
25 enrolled 16 charts
Head & Neck

Nasopharyngeal Carcinoma

NCT00337987 2015-02-27

A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma

Yale University

Phase 2 Completed
49 enrolled 6 charts
Lymphoid

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡